Pharmacological Profile of a Tachykinin Antagonist, Spantide, as Examined on Rat Spinal Motoneurones

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.1990.tb14080.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Pharmacological Profile of TP-680, a New cholecystokininA Receptor Antagonist

British Journal of Pharmacology
Pharmacology
1996English

Pharmacological Profile of Non-Vitamin K Antagonist Oral Anticoagulants

African Journal of Pharmacy and Pharmacology
2017English

Pharmacological Profile of VP-343, a Novel Selective Vasopressin V2 Receptor Antagonist, in Rats.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2000English

(±)-Cp-96,345, a Selective Tachykinin NK1 Receptor Antagonist, Has Non-Specific Actions on Neurotransmission

British Journal of Pharmacology
Pharmacology
1992English

Effect of TAK-637, a Tachykinin NK1-Receptor Antagonist, on Lower Urinary Tract Function in Cats.

The Japanese Journal of Pharmacology
2001English

Solving Words as Anagrams: A Re-Examined Issue Examined

Psychonomic Science
1966English

Effect of RP 67580, a Non-Peptide Neurokinin1 Receptor Antagonist, on Facilitation of a Nociceptive Spinal Flexion Reflex in the Rat

British Journal of Pharmacology
Pharmacology
1993English

Contractile Effects by Intracellular Angiotensin IIviareceptors With a Distinct Pharmacological Profile in Rat Aorta

British Journal of Pharmacology
Pharmacology
1999English

A Novel Tachykinin NK2 Receptor Antagonist Prevents Motility-Stimulating Effects of Neurokinin a in Small Intestine

British Journal of Pharmacology
Pharmacology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy